OP27. THE TREATMENT OF GIANT CELL ARTERITIS WITH BIOLOGIC AGENTS

Successful Antiviral Treatment of Giant Cell Arteritis and Takayasu Arteritis.

Author Affiliations:Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada (Bourassa, Dion, Rouleau); Group for AdvancedMolecular Investigation, Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil (Raskin); Genetika–Centro de Aconselhamento e Laboratório de G...

Treatment of resistant giant cell arteritis with etanercept.

Correlation Between Immunohistochemical Profile of Giant Cell Granuloma with Pathogenesis and Biologic Behavior: A Review Article

Abstract: Background and Aim: Giant cell Granulomas (central and peripheral) are two fairly common lesions of the oral cavity with uncertain etiology and pathogenesis. As well, the reason for their different biologic behavior is not well understood yet. This study aimed to review the immunohistochemical profile of giant cell granuloma and its correlation with pathogenesis and biologic behavior....

The diagnosis and treatment of giant cell arteritis.

BACKGROUND Giant cell arteritis (GCA) is the most common systemic vasculitis in persons aged 50 and above (incidence, 3.5 per 100,000 per year). It affects cranial arteries, the aorta, and arteries elsewhere in the body, e.g., in the limbs. METHODS We selectively review the pertinent literature, including guidelines and recommendations from Germany and abroad. RESULTS The typical symptoms o...

Biological agents for giant cell arteritis: treat to target.

In a case series published in the Annals of the Rheumatic Diseases, Conway et al reported a significant steroid-sparing effect of ustekinumab (monoclonal antibody to interleukin (IL)-12 and IL-23) in 14 patients with giant cell arteritis (GCA). Recently, Ferfar et al summarised current evidence showing the efficacy of tocilizumab and abatacept in patients with GCA. In the ongoing multicentre, r...